Abstract
Protection against Mycobacterium
tuberculosis is based on cell-mediated immunity, most importantly
involving
Protection against Mycobacterium
tuberculosis is based on cell-mediated immunity, most importantly
involving
W H Boom, D H Canaday, S A Fulton, A J Gehring, R E Rojas, and M Torres, “Human immunity to M. tuberculosis: T cell subsets and antigen processing,” Tuberculosis (Edinburgh), vol. 83, no. 1–3, pp. 98–106, 2003.
View at: Google ScholarJ Talreja, A Bhatnagar, S K Jindal, and N K Ganguly, “Influence of Mycobacterium tuberculosis on differential activation of helper T-cells,” Clinical and Experimental Immunology, vol. 131, no. 2, pp. 292–298, 2003.
View at: Google ScholarJ A Pilheu, M C De Salvo, J Gonzalez, D Rey, M C Elias, and M C Ruppi, “CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection,” The International Journal of Tuberculosis and Lung Disease, vol. 1, no. 5, pp. 422–426, 1997.
View at: Google ScholarD Dlugovitzky, A Torres-Morales, L Rateni et al., “Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement,” FEMS Immunology and Medical Microbiology, vol. 18, no. 3, pp. 203–207, 1997.
View at: Google ScholarAmerican Thoracic Society, “Diagnostic standard and classification of tuberculosis,” The American Review of Respiratory Disease, vol. 142, pp. 725–735, 1990.
View at: Google ScholarJ Montes Santiago, F Gambon Deza, M Pacheco Carracedo, and T Cerda Mota, “Cellular immune response in tuberculosis: analysis of T-lymphocytes and their subsets, B-lymphocytes and natural cytotoxic cells in different tuberculosis states and body fluids,” Revista Clinica Espanola, vol. 196, no. 4, pp. 223–227, 1996.
View at: Google ScholarB E Jones, M M Oo, E K Taikwel et al., “CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis,” Clinical Infectious Diseases, vol. 24, no. 5, pp. 988–991, 1997.
View at: Google ScholarI M Orme, P Andersen, and W H Boom, “T cell response to Mycobacterium tuberculosis,” The Journal of Infectious Diseases, vol. 167, no. 6, pp. 1481–1497, 1993.
View at: Google ScholarC T Yu, C H Wang, T J Huang, H C Lin, and H P Kuo, “Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis,” Thorax, vol. 50, no. 8, pp. 869–874, 1995.
View at: Google ScholarA C Carvalho, A Matteelli, P Airo et al., “gamma/delta T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection,” Thorax, vol. 57, no. 4, pp. 357–360, 2002.
View at: Google ScholarJ K Onwubalili, A J Edwards, and L Palmer, “T4 lymphopenia in human tuberculosis,” Tubercle, vol. 68, no. 3, pp. 195–200, 1987.
View at: Google ScholarG M Ainslie, J A Solomon, and E D Bateman, “Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery,” Thorax, vol. 47, no. 7, pp. 513–518, 1992.
View at: Google ScholarM D Ashtekar, A M Samuel, G V Kadival, V Sakhalkar, S Rajadhyaksha, and S S Virdi, “T lymphocytes in pulmonary tuberculosis,” The Indian Journal of Medical Research, vol. 97, pp. 14–17, 1993.
View at: Google ScholarM Singhal, J N Banavalikar, S Sharma, and K Saha, “Peripheral blood T lymphocyte subpopulations in patients with tuberculosis and the effect of chemotherapy,” Tubercle, vol. 70, no. 3, pp. 171–178, 1989.
View at: Google ScholarN Shijubo, F Nakanishi, M Hirasawa et al., “Phenotypic analysis in peripheral blood lymphocytes of patients with pulmonary tuberculosis,” Kekkaku, vol. 67, no. 9, pp. 581–585, 1992 (Japanese).
View at: Google ScholarP Yildiz, F Kadakal, Y Tutuncu et al., “Natural killer cell activity in multidrug-resistant pulmonary tuberculosis,” Respiration, vol. 68, no. 6, pp. 590–594, 2001.
View at: Google ScholarG S Turett and E E Telzak, “Normalization of CD4+ T-lymphocyte depletion in patients without HIV infection treated for tuberculosis,” Chest, vol. 105, no. 5, pp. 1335–1337, 1994.
View at: Google ScholarS S Uppal, S C Tewari, S Verma, and P S Dhot, “Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study,” Cytometry. Part B, Clinical Cytometry, vol. 61, no. 1, pp. 20–26, 2004.
View at: Google ScholarH M Vordermeier, N Venkataprasad, D P Harris, and J Ivanyi, “Increase of tuberculous infection in the organs of B cell-deficient mice,” Clinical and Experimental Immunology, vol. 106, no. 2, pp. 312–316, 1996.
View at: Google ScholarC M Johnson, A M Cooper, A A Frank, C B Bonorino, L J Wysoki, and I M Orme, “Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice,” Tubercle and Lung Disease, vol. 78, no. 5-6, pp. 257–261, 1997.
View at: Google ScholarM Corominas, V Cardona, L Gonzalez et al., “B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection,” The International Journal of Tuberculosis and Lung Disease, vol. 8, no. 1, pp. 98–105, 2004.
View at: Google ScholarL E Bermudez and L S Young, “Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages,” Journal of Immunology, vol. 146, no. 1, pp. 265–270, 1991.
View at: Google ScholarK V Harshan and P R Gangadharam, “In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice,” Infection and Immunity, vol. 59, no. 8, pp. 2818–2821, 1991.
View at: Google ScholarA P Junqueira-Kipnis, A Kipnis, A Jamieson et al., “NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection,” Journal of Immunology, vol. 171, no. 11, pp. 6039–6045, 2003.
View at: Google ScholarT Yoneda and J J Ellner, “CD T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 2, pp. 395–403, 1998.
View at: Google ScholarT Yoneda, M Kasai, J Ishibashi, K Nishikawa, T Tokunaga, and R Mikami, “NK cell activity in pulmonary tuberculosis,” British Journal of Diseases of the Chest, vol. 77, no. 2, pp. 185–188, 1983.
View at: Google ScholarJ Qin, “NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis,” Zhonghua Jie He He Hu Xi Za Zhi, vol. 13, no. 4, pp. 209–211, 1990 (Chinese).
View at: Google ScholarS Saenghirunvattana, “CD4 + T counts with a course of antituberculous therapy in healthy and HIV-infected patients,” Journal of the Medical Association of Thailand, vol. 79, no. 4, pp. 246–248, 1996.
View at: Google ScholarR Nirmala, P R Narayanan, R Mathew, M Maran, and C N Deivanayagam, “Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity,” Tuberculosis (Edinburgh), vol. 81, no. 5-6, pp. 343–352, 2001.
View at: Google ScholarF Morikawa, A Nakano, H Nakano, F Oseko, and S Morikawa, “Enhanced natural killer cell activity in patients with pulmonary tuberculosis,” Japanese Journal of Medicine, vol. 28, no. 3, pp. 316–322, 1989.
View at: Google ScholarR A Taha, T C Kotsimbos, Y L Song, D Menzies, and Q Hamid, “IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 3, pp. 1135–1139, 1997.
View at: Google ScholarI V Lyadova, E B Eruslanov, S V Khaidukov et al., “Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease,” Journal of Immunology, vol. 165, no. 10, pp. 5921–5931, 2000.
View at: Google Scholar